Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 803

1.

Deep learning-based virtual non-contrast CT for volumetric modulated arc therapy planning: Comparison with a dual-energy CT-based approach.

Koike Y, Ohira S, Akino Y, Sagawa T, Yagi M, Ueda Y, Miyazaki M, Sumida I, Teshima T, Ogawa K.

Med Phys. 2019 Nov 16. doi: 10.1002/mp.13925. [Epub ahead of print]

PMID:
31733105
2.

Anagrelide Modulates Proplatelet Formation Resulting in Decreased Number and Increased Size of Platelets.

Miyashita N, Onozawa M, Yokoyama S, Hidaka D, Hayasaka K, Kunishima S, Teshima T.

Hemasphere. 2019 Aug 7;3(4):e268. doi: 10.1097/HS9.0000000000000268. eCollection 2019 Aug.

PMID:
31723843
3.

Short-term KRP203 and posttransplant cyclophosphamide for graft-versus-host disease prophylaxis.

Yokoyama E, Hashimoto D, Hayase E, Ara T, Ogasawara R, Takahashi S, Ohigashi H, Tateno T, Hasegawa Y, Chen X, Teshima T.

Bone Marrow Transplant. 2019 Nov 4. doi: 10.1038/s41409-019-0733-8. [Epub ahead of print]

PMID:
31685933
4.

Impact of a training program incorporating cardiac magnetic resonance imaging on the accuracy and reproducibility of two-dimensional echocardiographic measurements of left ventricular volumes and ejection fraction.

Nabeshima Y, Namisaki H, Teshima T, Kurashige Y, Kakio A, Fukumitsu A, Otsuji Y, Takeuchi M.

Cardiovasc Ultrasound. 2019 Oct 31;17(1):23. doi: 10.1186/s12947-019-0173-z.

5.

Japanese Structure Survey of Radiation Oncology in 2011.

Numasaki H, Teshima T, Nishimura T, Akuta K, Ando Y, Ikeda H, Kamikonya N, Koizumi M, Sasaki T, Sekiguchi K, Tago M, Terahara A, Nakamura K, Nishio M, Murakami M, Mori Y, Ogawa K; Japanese Society for Radiation Oncology Database Committee.

J Radiat Res. 2019 Oct 28. pii: rrz058. doi: 10.1093/jrr/rrz058. [Epub ahead of print]

PMID:
31665374
6.

Assessment of myocardial function in obstructive hypertrophic cardiomyopathy cats with and without response to medical treatment by carvedilol.

Suzuki R, Mochizuki Y, Yuchi Y, Yasumura Y, Saito T, Teshima T, Matsumoto H, Koyama H.

BMC Vet Res. 2019 Oct 28;15(1):376. doi: 10.1186/s12917-019-2141-0.

7.

Volumetric modulated arc therapy treatment planning based on virtual monochromatic images for head and neck cancer: effect of the contrast-enhanced agent on dose distribution.

Komiyama R, Ohira S, Kanayama N, Karino T, Washio H, Ueda Y, Miyazaki M, Teshima T.

J Appl Clin Med Phys. 2019 Nov;20(11):144-152. doi: 10.1002/acm2.12752. Epub 2019 Oct 21.

PMID:
31633869
8.

Elucidation of the Interaction between Flavan-3-ols and Bovine Serum Albumin and Its Effect on Their In-Vitro Cytotoxicity.

Fujii Y, Suhara Y, Sukikara Y, Teshima T, Hirota Y, Yoshimura K, Osakabe N.

Molecules. 2019 Oct 11;24(20). pii: E3667. doi: 10.3390/molecules24203667.

9.

Loss of nivolumab binding to T cell PD-1 predicts relapse of Hodgkin lymphoma.

Ogasawara R, Hashimoto D, Sugita J, Yamawaki F, Naka T, Mitsuhashi T, Takahashi S, Miyashita N, Okada K, Onozawa M, Matsuno Y, Teshima T.

Int J Hematol. 2019 Sep 19. doi: 10.1007/s12185-019-02737-4. [Epub ahead of print]

PMID:
31538325
10.

Dosimetric effect of rotational setup errors in stereotactic radiosurgery with HyperArc for single and multiple brain metastases.

Sagawa T, Ohira S, Ueda Y, Akino Y, Mizuno H, Matsumoto M, Miyazaki M, Koizumi M, Teshima T.

J Appl Clin Med Phys. 2019 Oct;20(10):84-91. doi: 10.1002/acm2.12716. Epub 2019 Sep 11.

11.

A prospective observational study of immune reconstitution following transplantation with post-transplant reduced-dose cyclophosphamide from HLA-haploidentical donors.

Nakamae H, Fujii K, Nanno S, Okamura H, Nakane T, Koh H, Nakashima Y, Nakamae M, Hirose A, Teshima T, Hino M.

Transpl Int. 2019 Aug 20. doi: 10.1111/tri.13494. [Epub ahead of print]

PMID:
31432532
12.

Effect of collimator angle on HyperArc stereotactic radiosurgery planning for single and multiple brain metastases.

Ohira S, Sagawa T, Ueda Y, Inui S, Masaoka A, Akino Y, Mizuno H, Miyazaki M, Koizumi M, Teshima T.

Med Dosim. 2019 Aug 1. pii: S0958-3947(19)30080-9. doi: 10.1016/j.meddos.2019.07.004. [Epub ahead of print]

PMID:
31378401
13.

Clinical significance of end-diastolic opening of pulmonary valve in a case complicating left ventricular systolic dysfunction.

Nishino H, Iwano H, Kaga S, Nishida M, Akizawa K, Teshima T, Anzai T.

J Echocardiogr. 2019 Aug 3. doi: 10.1007/s12574-019-00438-9. [Epub ahead of print] No abstract available.

PMID:
31377950
14.

Dual Sympathetic Input into Developing Salivary Glands.

Teshima THN, Tucker AS, Lourenço SV.

J Dent Res. 2019 Sep;98(10):1122-1130. doi: 10.1177/0022034519865222. Epub 2019 Jul 29.

PMID:
31356755
15.

Carbon 11-choline positron emission tomography/computed tomography and palliative local therapy for castration-resistant prostate cancer.

Nozaki K, Kawai T, Fujimura T, Matsui H, Teshima T, Oshina T, Takahashi A, Sato Y, Yamada D, Azuma T, Hotta M, Nakajima K, Nakayama H, Minamimoto R, Kume H.

Int Urol Nephrol. 2019 Oct;51(10):1763-1769. doi: 10.1007/s11255-019-02233-y. Epub 2019 Jul 19.

PMID:
31325132
16.

Effect of a saline flush technique for head and neck imaging in dual-energy CT: improvement of image quality and perivenous artefact reduction using virtual monochromatic imaging.

Washio H, Ohira S, Kanayama N, Wada K, Karino T, Komiyama R, Miyazaki M, Teshima T.

Clin Radiol. 2019 Oct;74(10):805-812. doi: 10.1016/j.crad.2019.06.010. Epub 2019 Jul 15.

PMID:
31320111
17.

Safety and efficacy of amnion-derived mesenchymal stem cells (AM01) in patients with steroid-refractory acute graft-versus-host disease after allogeneic haematopoietic stem cell transplantation: a study protocol for a phase I/II Japanese trial.

Yamahara K, Hamada A, Soma T, Okamoto R, Okada M, Yoshihara S, Yoshihara K, Ikegame K, Tamaki H, Kaida K, Inoue T, Ohsugi Y, Nishikawa H, Hayashi H, Ito YM, Iijima H, Ohnishi S, Hashimoto D, Isoe T, Teshima T, Ogawa H, Sato N, Fujimori Y.

BMJ Open. 2019 Jul 9;9(7):e026403. doi: 10.1136/bmjopen-2018-026403.

18.

Clinical efficacy and safety of first-line nilotinib therapy and evaluation of the clinical utility of the FRET-based drug sensitivity test.

Kondo T, Fujioka M, Fujisawa S, Sato K, Tsuda M, Miyagishima T, Mori A, Iwasaki H, Kakinoki Y, Yamamoto S, Haseyama Y, Ando S, Shindo M, Ota S, Kurosawa M, Ohba Y, Teshima T; North Japan Hematology Study Group (NJHSG).

Int J Hematol. 2019 Oct;110(4):482-489. doi: 10.1007/s12185-019-02696-w. Epub 2019 Jun 25.

PMID:
31240558
19.

Failure patterns after adjuvant chemoradiotherapy following endoscopic resection for superficial esophageal squamous cell carcinoma.

Ikawa T, Ishihara R, Konishi K, Morimoto M, Hirata T, Kanayama N, Yamamoto S, Matsuura N, Wada K, Hayashi K, Ogawa K, Teshima T.

Cancer Med. 2019 Aug;8(10):4547-4554. doi: 10.1002/cam4.2365. Epub 2019 Jun 20.

20.

Dosimetric performance of two linear accelerator-based radiosurgery systems to treat single and multiplebrain metastases.

Ueda Y, Ohira S, Yamazaki H, Mabuchi N, Higashinaka N, Miyazaki M, Teshima T.

Br J Radiol. 2019 Aug;92(1100):20190004. doi: 10.1259/bjr.20190004. Epub 2019 Jun 12.

PMID:
31188018
21.

Inferior Outcomes with Cyclosporine and Mycophenolate Mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

Hamilton BK, Liu Y, Hemmer MT, Majhail N, Ringden O, Kim D, Costa L, Stuart R, Alousi A, Pidala JA, Couriel DR, Aljurf M, Antin JH, Bredeson C, Cahn JY, Cairo M, Choi SW, Dandoy C, Gale RP, Gergis U, Hematti P, Inamoto Y, Kamble RT, MacMillan M, Marks DI, Nemecek E, Nishihori T, Saad A, Savani BN, Schriber J, Seo S, Socié G, Teshima T, Verdonck LF, Waller EK, Wirk M, Spellman SR, Arora M, Chhabra S.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1744-1755. doi: 10.1016/j.bbmt.2019.05.019. Epub 2019 May 31.

PMID:
31158502
22.

Graphene-based neuron encapsulation with controlled axonal outgrowth.

Sakai K, Teshima TF, Nakashima H, Ueno Y.

Nanoscale. 2019 Jul 28;11(28):13249-13259. doi: 10.1039/c9nr04165f. Epub 2019 May 31.

PMID:
31149690
23.

Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.

Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1851-1858. doi: 10.1016/j.bbmt.2019.05.016. Epub 2019 May 24.

PMID:
31129353
24.

Impact of T Cell Dose on Outcome of T Cell-Replete HLA-Matched Allogeneic Peripheral Blood Stem Cell Transplantation.

Saad A, Lamb L, Wang T, Hemmer MT, Spellman S, Couriel D, Alousi A, Pidala J, Abdel-Azim H, Agrawal V, Aljurf M, Beitinjaneh AM, Bhatt VR, Buchbinder D, Byrne M, Cahn JY, Cairo M, Castillo P, Chhabra S, Diaz MA, Farhan S, Floisand Y, Frangoul HA, Gadalla SM, Gajewski J, Gale RP, Gandhi M, Gergis U, Hamilton BK, Hematti P, Hildebrandt GC, Kamble RT, Kanate AS, Khandelwal P, Lazaryan A, MacMillan M, Marks DI, Martino R, Mehta PA, Nishihori T, Olsson RF, Patel SS, Qayed M, Rangarajan HG, Reshef R, Ringden O, Savani BN, Schouten HC, Schultz KR, Seo S, Shaffer BC, Solh M, Teshima T, Urbano-Ispizua A, Verdonck LF, Vij R, Waller EK, William B, Wirk B, Yared JA, Yu LC, Arora M, Hashmi S.

Biol Blood Marrow Transplant. 2019 Sep;25(9):1875-1883. doi: 10.1016/j.bbmt.2019.05.007. Epub 2019 May 11.

PMID:
31085303
25.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

Mehta RS, Holtan SG, Wang T, Hemmer MT, Spellman SR, Arora M, Couriel DR, Alousi AM, Pidala J, Abdel-Azim H, Ahmed I, Aljurf M, Askar M, Auletta JJ, Bhatt V, Bredeson C, Chhabra S, Gadalla S, Gajewski J, Gale RP, Gergis U, Hematti P, Hildebrandt GC, Inamoto Y, Kitko C, Khandelwal P, MacMillan ML, Majhail N, Marks DI, Mehta P, Nishihori T, Olsson RF, Pawarode A, Diaz MA, Prestidge T, Qayed M, Rangarajan H, Ringden O, Saad A, Savani BN, Seo S, Shah A, Shah N, Schultz KR, Solh M, Spitzer T, Szer J, Teshima T, Verdonck LF, Williams KM, Wirk B, Wagner J, Yared JA, Weisdorf DJ.

Blood Adv. 2019 May 14;3(9):1441-1449. doi: 10.1182/bloodadvances.2018030171.

26.

The myeloid differentiation factor 88 signaling in donor T cells accelerates graft-versus-host disease.

Matsuoka S, Hashimoto D, Kadowaki M, Ohigashi H, Hayase E, Yokoyama E, Hasegawa Y, Tateno T, Chen X, Aoyama K, Oka H, Onozawa M, Takeda K, Akashi K, Teshima T.

Haematologica. 2019 May 2. pii: haematol.2018.203380. doi: 10.3324/haematol.2018.203380. [Epub ahead of print]

27.

Volumetric modulated arc therapy planning based on virtual monochromatic images: Effect of inaccurate CT numbers on dose distributions.

Ohira S, Komiyama R, Karino T, Washio H, Ueda Y, Miyazaki M, Koizumi M, Teshima T.

Phys Med. 2019 Apr;60:83-90. doi: 10.1016/j.ejmp.2019.03.022. Epub 2019 Mar 29.

PMID:
31000091
28.

Validation of US evaluation of ulcerative colitis activity.

Omotehara S, Nishida M, Kinoshita K, Onishi R, Onodera A, Suya M, Hasegawa T, Mitsumori D, Katsurada T, Teshima T.

Ultrasound Med Biol. 2019 Jul;45(7):1537-1544. doi: 10.1016/j.ultrasmedbio.2019.02.018. Epub 2019 Apr 12.

PMID:
30987912
29.

Gene Polymorphism of Tacrolimus-Metabolizing Enzymes Associated With Impaired Absorption of Tacrolimus Following Allogeneic Hematopoietic Stem Cell Transplantation: A Case Report.

Matsuoka S, Tsutsumi Y, Kikuchi R, Ito S, Teshima T.

Transplant Proc. 2019 Apr;51(3):998-1001. doi: 10.1016/j.transproceed.2019.01.061. Epub 2019 Jan 26.

PMID:
30979494
30.

FGF10 is an essential regulator of tracheal submucosal gland morphogenesis.

May AJ, Teshima THN, Noble A, Tucker AS.

Dev Biol. 2019 Jul 15;451(2):158-166. doi: 10.1016/j.ydbio.2019.03.017. Epub 2019 Apr 6.

PMID:
30965042
31.

Left ventricular geometric characteristics predict response to carvedilol in cats with asymptomatic hypertrophic obstructive cardiomyopathy caused by systolic anterior motion of the mitral valve.

Mochizuki Y, Suzuki R, Yasumura Y, Saito T, Teshima T, Matsumoto H, Koyama H.

J Vet Med Sci. 2019 May 31;81(5):734-738. doi: 10.1292/jvms.18-0718. Epub 2019 Apr 2.

32.

Ocular instillation of vitamin A-coupled liposomes containing HSP47 siRNA ameliorates dry eye syndrome in chronic GVHD.

Ohigashi H, Hashimoto D, Hayase E, Takahashi S, Ara T, Yamakawa T, Sugita J, Onozawa M, Nakagawa M, Teshima T.

Blood Adv. 2019 Apr 9;3(7):1003-1010. doi: 10.1182/bloodadvances.2018028431.

33.

Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation.

Toffalori C, Zito L, Gambacorta V, Riba M, Oliveira G, Bucci G, Barcella M, Spinelli O, Greco R, Crucitti L, Cieri N, Noviello M, Manfredi F, Montaldo E, Ostuni R, Naldini MM, Gentner B, Waterhouse M, Zeiser R, Finke J, Hanoun M, Beelen DW, Gojo I, Luznik L, Onozawa M, Teshima T, Devillier R, Blaise D, Halkes CJM, Griffioen M, Carrabba MG, Bernardi M, Peccatori J, Barlassina C, Stupka E, Lazarevic D, Tonon G, Rambaldi A, Cittaro D, Bonini C, Fleischhauer K, Ciceri F, Vago L.

Nat Med. 2019 Apr;25(4):603-611. doi: 10.1038/s41591-019-0400-z. Epub 2019 Mar 25.

PMID:
30911134
34.

Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.

Noviello M, Manfredi F, Ruggiero E, Perini T, Oliveira G, Cortesi F, De Simone P, Toffalori C, Gambacorta V, Greco R, Peccatori J, Casucci M, Casorati G, Dellabona P, Onozawa M, Teshima T, Griffioen M, Halkes CJM, Falkenburg JHF, Stölzel F, Altmann H, Bornhäuser M, Waterhouse M, Zeiser R, Finke J, Cieri N, Bondanza A, Vago L, Ciceri F, Bonini C.

Nat Commun. 2019 Mar 25;10(1):1065. doi: 10.1038/s41467-019-08871-1.

35.

Serum level of soluble interleukin-2 receptor is positively correlated with metabolic tumor volume on 18 F-FDG PET/CT in newly diagnosed patients with diffuse large B-cell lymphoma.

Senjo H, Kanaya M, Izumiyama K, Minauchi K, Hirata K, Mori A, Saito M, Tanaka M, Iijima H, Tsukamoto E, Itoh K, Ota S, Morioka M, Hashimoto D, Teshima T; North Japan Hematology Study Group (NJHSG).

Cancer Med. 2019 Mar;8(3):953-962. doi: 10.1002/cam4.1973. Epub 2019 Feb 20.

36.

Ibrutinib Caused Mediastinal Emphysema and Pneumothorax in the Treatment of a Patient with Mantle Cell Lymphoma.

Tsutsumi Y, Sekine T, Ito S, Matsuoka S, Teshima T.

Drug Saf Case Rep. 2019 Feb 21;6(1):3. doi: 10.1007/s40800-019-0098-3.

37.

A role for IL-34 in osteolytic disease of multiple myeloma.

Baghdadi M, Ishikawa K, Nakanishi S, Murata T, Umeyama Y, Kobayashi T, Kameda Y, Endo H, Wada H, Bogen B, Yamamoto S, Yamaguchi K, Kasahara I, Iwasaki H, Takahata M, Ibata M, Takahashi S, Goto H, Teshima T, Seino KI.

Blood Adv. 2019 Feb 26;3(4):541-551. doi: 10.1182/bloodadvances.2018020008.

38.

A genetic variant of CYP2R1 identified in a cat with type 1B vitamin D-dependent rickets: a case report.

Teshima T, Kurita S, Sasaki T, Matsumoto H, Niina A, Abe D, Kanno N, Koyama H.

BMC Vet Res. 2019 Feb 18;15(1):62. doi: 10.1186/s12917-019-1784-1.

39.

Ameloblastoma with distinctive granular cell pattern: an 8 case study.

Cadavid AMH, Teshima THN, Pinto CAL, Camillo CMC, Lourenço SV.

Autops Case Rep. 2018 Oct 9;8(4):e2018052. doi: 10.4322/acr.2018.052. eCollection 2018 Oct-Dec.

40.

Hyperadrenocorticism Caused by a Pituitary Ganglioglioma in a Dog.

Ishino H, Takekoshi S, Teshima T, Uchida K, Sakonju I, Hara Y.

Vet Pathol. 2019 Jul;56(4):609-613. doi: 10.1177/0300985819829530. Epub 2019 Feb 17.

PMID:
30774022
41.

Clinicopathological features of HCV-positive splenic diffuse large B cell lymphoma.

Shimono J, Miyoshi H, Arakawa F, Yamada K, Sugio T, Miyawaki K, Eto T, Miyagishima T, Kato K, Nagafuji K, Akashi K, Teshima T, Ohshima K.

Ann Hematol. 2019 May;98(5):1197-1207. doi: 10.1007/s00277-019-03628-8. Epub 2019 Feb 7.

PMID:
30729289
42.

Radiotherapy alone as a possible de-intensified treatment for human papillomavirus-related locally advanced oropharyngeal squamous cell carcinoma.

Yamamoto Y, Takemoto N, Michiba T, Seo Y, Isohashi F, Otani K, Suzuki M, Fujii T, Yoshii T, Mitani K, Yasui T, Cho H, Tomita Y, Morii E, Teshima T, Ogawa K, Inohara H.

Int J Clin Oncol. 2019 Jun;24(6):640-648. doi: 10.1007/s10147-019-01394-1. Epub 2019 Jan 29.

PMID:
30694402
43.

Frequent structural variations involving programmed death ligands in Epstein-Barr virus-associated lymphomas.

Kataoka K, Miyoshi H, Sakata S, Dobashi A, Couronné L, Kogure Y, Sato Y, Nishida K, Gion Y, Shiraishi Y, Tanaka H, Chiba K, Watatani Y, Kakiuchi N, Shiozawa Y, Yoshizato T, Yoshida K, Makishima H, Sanada M, Onozawa M, Teshima T, Yoshiki Y, Ishida T, Suzuki K, Shimada K, Tomita A, Kato M, Ota Y, Izutsu K, Demachi-Okamura A, Akatsuka Y, Miyano S, Yoshino T, Gaulard P, Hermine O, Takeuchi K, Ohshima K, Ogawa S.

Leukemia. 2019 Jul;33(7):1687-1699. doi: 10.1038/s41375-019-0380-5. Epub 2019 Jan 25.

44.

Comparison of Interfractional Setup Reproducibility between Two Types of Patient Immobilization Devices in Image-Guided Radiation Therapy for Prostate Cancer.

Inui S, Ueda Y, Ohira S, Isono M, Masaoka A, Murata S, Nitta Y, Karino T, Miyazaki M, Teshima T.

J Med Phys. 2018 Oct-Dec;43(4):230-235. doi: 10.4103/jmp.JMP_20_18.

45.

Impacts of thymoglobulin in patients with acute leukemia in remission undergoing allogeneic HSCT from different donors.

Wakamatsu M, Terakura S, Ohashi K, Fukuda T, Ozawa Y, Kanamori H, Sawa M, Uchida N, Ota S, Matsushita A, Kanda Y, Nakamae H, Ichinohe T, Kato K, Murata M, Atsuta Y, Teshima T; GVHD Working Group of the Japan Society for Hematopoietic Cell Transplantation.

Blood Adv. 2019 Jan 22;3(2):105-115. doi: 10.1182/bloodadvances.2018025643.

46.

Predictors of Acute Radiation Esophagitis in Non-small Cell Lung Cancer Patients Treated With Accelerated Hyperfractionated Chemoradiotherapy.

Wada K, Kishi N, Kanayama N, Hirata T, Ueda Y, Kawaguchi Y, Morimoto M, Konishi K, Imamura F, Ogawa K, Teshima T.

Anticancer Res. 2019 Jan;39(1):491-497. doi: 10.21873/anticanres.13139.

PMID:
30591500
47.

Estimation of electron density, effective atomic number and stopping power ratio using dual-layer computed tomography for radiotherapy treatment planning.

Ohira S, Washio H, Yagi M, Karino T, Nakamura K, Ueda Y, Miyazaki M, Koizumi M, Teshima T.

Phys Med. 2018 Dec;56:34-40. doi: 10.1016/j.ejmp.2018.11.008. Epub 2018 Nov 21.

PMID:
30527087
48.

Self-Folded Three-Dimensional Graphene with a Tunable Shape and Conductivity.

Teshima TF, Henderson CS, Takamura M, Ogawa Y, Wang S, Kashimura Y, Sasaki S, Goto T, Nakashima H, Ueno Y.

Nano Lett. 2019 Jan 9;19(1):461-470. doi: 10.1021/acs.nanolett.8b04279. Epub 2018 Dec 14.

PMID:
30525693
49.

Layer-specific myocardial function in asymptomatic cats with obstructive hypertrophic cardiomyopathy assessed using 2-dimensional speckle-tracking echocardiography.

Suzuki R, Mochizuki Y, Yoshimatsu H, Niina A, Teshima T, Matsumoto H, Koyama H.

J Vet Intern Med. 2019 Jan;33(1):37-45. doi: 10.1111/jvim.15339. Epub 2018 Nov 29.

50.

Quantitative detection of IKZF1 deletion by digital PCR in patients with acute lymphoblastic leukemia.

Hashiguchi J, Onozawa M, Okada K, Amano T, Hatanaka KC, Nishihara H, Sato N, Teshima T.

Int J Lab Hematol. 2019 Apr;41(2):e38-e40. doi: 10.1111/ijlh.12945. Epub 2018 Nov 20. No abstract available.

PMID:
30457697

Supplemental Content

Loading ...
Support Center